{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T01:57:58Z","timestamp":1776131878219,"version":"3.50.1"},"reference-count":46,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2001,12,20]],"date-time":"2001-12-20T00:00:00Z","timestamp":1008806400000},"content-version":"vor","delay-in-days":353,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Br J Haematol"],"published-print":{"date-parts":[[2001,1]]},"abstract":"<jats:p>Between July 1992 and June 1996, 3934 new cases of acute leukaemia were registered in the Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto (GIMEMA) Archive of Adult Acute Leukaemia. Two hundred cases (5\u00b71%) presented with a history of primary malignancy (PM), 179 of which were acute myeloid leukaemia (AML). The median age of these cases was significantly higher than that of other primitive AML (63\u2003years vs. 57\u2003years; <jats:italic>P<\/jats:italic>\u2003&lt;\u20030\u00b7001). The number of men was significantly lower than the number of women [74\/1544 (4\u00b78%) vs. 105\/1420 (7\u00b74%); odds ratio (OR) 0\u00b763, 95% confidence interval (CI) 0\u00b746\u20130\u00b787; <jats:italic>P<\/jats:italic>\u2003&lt;\u20030\u00b7002], as was the number of patients aged &lt;\u200a65\u2003years [104\/1963 (5\u00b73%) vs. 75\/1001 (7\u00b75%); OR 0\u00b769, 95% CI 0\u00b750\u20130\u00b795; <jats:italic>P<\/jats:italic>\u2003&lt;\u20030\u00b701]. An increased incidence of cancer was observed among first\u2010degree relatives of patients with AML occurring after a PM (secondary AML; sAML) [66\/179 (36\u00b79%) sAML vs. 757\/2785 (27\u00b72%) <jats:italic>de novo<\/jats:italic> AML, age adjusted; OR 2\u00b762, 95% CI 1\u00b707\u20136\u00b742; <jats:italic>P<\/jats:italic>\u2003&lt;\u20030\u00b7005]. Prevalent types of PM were breast cancer, lymphoma and Hodgkin's disease. sAML occurred after a median latency of\u00a052\u2003months (range 2\u2013379). Of the 122 patients who\u00a0received chemotherapy for sAML, 67 patients (55%) achieved a complete remission (CR), three a partial remission, 15 (12%) died in induction and 37 (30%) were unresponsive. The median duration of CR was 30\u2003weeks (range 4\u2013250). The median overall survival was 7\u2003months (range 1\u2013196). Comparing acute promyelocytic leukaemia with all other French\u2013American\u2013British (FAB) groups, a significant increase in CR achievement was observed [14\/18 (77\u00b77%) vs. 53\/101 (52\u00b74%), <jats:italic>P<\/jats:italic>\u2003&lt;\u20030\u00b7046] as well as in median CR duration (55 vs. 24\u2003months, <jats:italic>P<\/jats:italic>\u2003&lt;\u20030\u00b702). The analysis of our data suggests that not only previous chemotherapy but also genetic predisposition could play a role in the pathogenesis of sAML.<\/jats:p>","DOI":"10.1046\/j.1365-2141.2001.02527.x","type":"journal-article","created":{"date-parts":[[2002,7,26]],"date-time":"2002-07-26T10:10:00Z","timestamp":1027678200000},"page":"109-117","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":47,"title":["Clinical and biological features of acute myeloid leukaemia occurring as second malignancy: GIMEMA archive of adult acute leukaemia"],"prefix":"10.1111","volume":"112","author":[{"given":"Livio","family":"Pagano","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessandro","family":"Pulsoni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Elena","family":"Tosti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giuseppe","family":"Avvisati","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luca","family":"Mele","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alfonso","family":"Mele","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bruno","family":"Martino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giuseppe","family":"Visani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raffaella","family":"Cerri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eros","family":"Di Bona","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rosangela","family":"Invernizzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Annamaria","family":"Nosari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marino","family":"Clavio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bernardino","family":"Allione","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paolo","family":"Coser","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Candoni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessandro","family":"Levis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Camera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lorella","family":"Melillo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giuseppe","family":"Leone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Franco","family":"Mandelli for the Gimema (gruppo Italiano Malattie Ematologic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2001,12,20]]},"reference":[{"key":"e_1_2_6_2_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1990.8.7.1148"},{"key":"e_1_2_6_3_1","first-page":"S1","article-title":"Acute Leukaemia Forum'98. Advances and controversies in the biology and treatment of acute myelogenous leukaemia and myelodysplasia; symposium proceedings. San Francisco, California, USA. March 6, 1998","volume":"12","author":"Anonymous.","year":"1998","journal-title":"Leukaemia"},{"key":"e_1_2_6_4_1","first-page":"19","volume-title":"Stima Dell'incidenza e Mortalit\u00e0 per Tumore nelle Regioni Italiane","author":"Belzi D.","year":"1997"},{"key":"e_1_2_6_5_1","doi-asserted-by":"crossref","first-page":"4296","DOI":"10.1182\/blood.V88.11.4296.bloodjournal88114296","article-title":"Microsatellite instability and p53 mutations in therapy\u2010related leukaemia suggest mutator phenotype","volume":"88","author":"Ben\u2010Jehuda D.","year":"1996","journal-title":"Blood"},{"key":"e_1_2_6_6_1","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19900201)65:3 <770::AID-CNCR2820651323>3.0.CO;2-8"},{"key":"e_1_2_6_7_1","first-page":"60","article-title":"Acute leukemia occurring in a primary neoplasia (secondary leukemia). A review on biological, epidemiological and clinical aspects","volume":"71","author":"Brusamolino E.","year":"1986","journal-title":"Haematologica"},{"key":"e_1_2_6_8_1","first-page":"812","article-title":"The risk of acute leukaemia in patients treated for Hodgkin's disease is significantly higher after combined modality programs than after\u00a0chemotherapy alone and is correlated with the extent of\u00a0radiotherapy and type and duration of chemotherapy. a case\u2013control study","volume":"83","author":"Brusamolino E.","year":"1998","journal-title":"Haematologica"},{"key":"e_1_2_6_9_1","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(196707)20:7<1080::AID-CNCR2820200711>3.0.CO;2-O"},{"key":"e_1_2_6_10_1","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.1987.201"},{"key":"e_1_2_6_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/0165-4608(88)90192-6"},{"key":"e_1_2_6_12_1","first-page":"1805","article-title":"Intensive chemotherapy for poor prognosis myelodyplasia (MDS) and secondary acute myeloid leukaemia (sAML) following MDS of more than 6 months duration. A pilot study by the Leukaemia Cooperative Group of the European Organisation for Research and Treatment in Cancer (EORTC\u2010LCG)","volume":"9","author":"De Witte T.","year":"1995","journal-title":"Leukaemia"},{"key":"e_1_2_6_13_1","first-page":"4451","article-title":"Association of\u00a0germline p53 mutation with MLL segmental jumping translocation in treatment\u2010related leukaemia","volume":"91","author":"Felix C.A.","year":"1998","journal-title":"Blood"},{"key":"e_1_2_6_14_1","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-105-3-360"},{"key":"e_1_2_6_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/0165-4608(84)90120-1"},{"key":"e_1_2_6_16_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.304.6832.951"},{"key":"e_1_2_6_17_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1989.tb07650.x"},{"key":"e_1_2_6_18_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199001043220102"},{"key":"e_1_2_6_19_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199001043220101"},{"key":"e_1_2_6_20_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1986.4.12.1748"},{"key":"e_1_2_6_21_1","first-page":"357","volume-title":"Neoplastic Diseases of the Blood","author":"Koeffler P.","year":"1985"},{"key":"e_1_2_6_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(97)01116-1"},{"key":"e_1_2_6_23_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1986.4.3.325"},{"key":"e_1_2_6_24_1","first-page":"47","article-title":"Leukemias and myelodysplastic syndromes secondary to drug, radiation, and environmental exposure","volume":"19","author":"Levine E.G.","year":"1992","journal-title":"Seminars in Oncology"},{"key":"e_1_2_6_25_1","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-129-6-199809150-00011"},{"key":"e_1_2_6_26_1","first-page":"983","article-title":"Colony formation in vitro by myelomonocytic leukaemia cells","volume":"43","author":"Metcalf F.D.","year":"1969","journal-title":"Journal of the National Cancer Institute"},{"key":"e_1_2_6_27_1","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1182\/blood.V90.9.3370","article-title":"Treatment of polycythemia vera: the use of hydroxyurea and piproman in 292 patients under the age of 65 years","volume":"90","author":"Najean Y.","year":"1997","journal-title":"Blood"},{"key":"e_1_2_6_28_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199111073251902"},{"key":"e_1_2_6_29_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.1999.01636.x"},{"key":"e_1_2_6_30_1","doi-asserted-by":"publisher","DOI":"10.1002\/(sici)1096-911x(199803)30:3<165::aid-mpo7>3.0.co;2-f"},{"key":"e_1_2_6_31_1","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1182\/blood.V78.4.1147.1147","article-title":"Balanced translocations involving chromosome bands 11q23 and 21q22 are highly characteristic of myelodysplasia and leukaemia following therapy with cytostatic agents targeting at DNA\u2010topoisomerase II","volume":"78","author":"Pedersen Bjergaard J.","year":"1991","journal-title":"Blood"},{"key":"e_1_2_6_32_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198210143071601"},{"key":"e_1_2_6_33_1","doi-asserted-by":"crossref","first-page":"3542","DOI":"10.1182\/blood.V86.9.3542.bloodjournal8693542","article-title":"Different genetic pathways in leukemogenesis for patients presenting with therapy\u2010related myelodysplasia and therapy\u2010related acute myeloid leukaemia","volume":"86","author":"Pedersen\u2010Bjergaard J.","year":"1995","journal-title":"Blood"},{"key":"e_1_2_6_34_1","doi-asserted-by":"publisher","DOI":"10.1016\/0165-4608(88)90221-X"},{"key":"e_1_2_6_35_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1040-8428(97)10029-4"},{"key":"e_1_2_6_36_1","doi-asserted-by":"publisher","DOI":"10.1016\/0145-2126(91)90005-E"},{"key":"e_1_2_6_37_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(97)90008-8"},{"key":"e_1_2_6_38_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199112123252402"},{"key":"e_1_2_6_39_1","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/S0889-8588(18)30337-X","article-title":"Therapy\u2010related myelodysplastic syndromes","volume":"6","author":"Rosenblood B.","year":"1992","journal-title":"Hematology and Oncology Clinics of North America"},{"key":"e_1_2_6_40_1","first-page":"151","article-title":"Breast cancer and acute leukaemia: report of 24 cases and review of the literature","volume":"4","author":"Rosner F.","year":"1978","journal-title":"American Journal of Medicine"},{"key":"e_1_2_6_41_1","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/88.7.407"},{"key":"e_1_2_6_42_1","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1200\/JCO.1995.13.7.1557","article-title":"Leukemogenic potential of adjuvant chemotherapy for early\u2010stage breast cancer: the Eastern Cooperative Oncology Group experience","volume":"13","author":"Tallman M.S.","year":"1995","journal-title":"Journal of Clinical Oncology"},{"key":"e_1_2_6_43_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0889-8588(05)70340-3"},{"key":"e_1_2_6_44_1","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1093\/oxfordjournals.annonc.a059008","article-title":"Second malignancies following CMF\u2010based adjuvant chemotherapy in resectable breast cancer","volume":"5","author":"Valagussa P.","year":"1994","journal-title":"Annals of Oncology"},{"key":"e_1_2_6_45_1","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1200\/JCO.1994.12.2.312","article-title":"Second cancer risk following Hodgkin's disease: a twenty\u2010year follow up study","volume":"12","author":"Van Leuween F.E.","year":"1994","journal-title":"Journal of Clinical Oncology"},{"key":"e_1_2_6_46_1","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1200\/JCO.1983.1.3.204","article-title":"Effective chemotherapy of acute myelocytic leukaemia occurring after alkylating agent or radiation therapy for prior malignancy","volume":"1","author":"Vaughan W.P.","year":"1983","journal-title":"Journal of Clinical Oncology"},{"key":"e_1_2_6_47_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1993.11.2.209"}],"container-title":["British Journal of Haematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2141.2001.02527.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2141.2001.02527.x","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1046\/j.1365-2141.2001.02527.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,17]],"date-time":"2023-10-17T01:33:57Z","timestamp":1697506437000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1046\/j.1365-2141.2001.02527.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,1]]},"references-count":46,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2001,1]]}},"alternative-id":["10.1046\/j.1365-2141.2001.02527.x"],"URL":"https:\/\/doi.org\/10.1046\/j.1365-2141.2001.02527.x","archive":["Portico"],"relation":{},"ISSN":["0007-1048","1365-2141"],"issn-type":[{"value":"0007-1048","type":"print"},{"value":"1365-2141","type":"electronic"}],"subject":[],"published":{"date-parts":[[2001,1]]},"assertion":[{"value":"2001-12-20","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}